Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124069387 | 12406938 | 7 | F | 2015 | 20160902 | 20160526 | 20160913 | EXP | CA-PFIZER INC-2016274790 | PFIZER | 53.00 | YR | F | Y | 0.00000 | 20160913 | CN | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124069387 | 12406938 | 1 | PS | Tecta | PANTOPRAZOLE MAGNESIUM | 1 | Oral | 40 MG, QD | Y | 20987 | 40 | MG | PROLONGED-RELEASE TABLET | QD | |||||
124069387 | 12406938 | 2 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | 40 MG, QD | 0 | 40 | MG | QD | |||||||
124069387 | 12406938 | 3 | SS | ENTYVIO | VEDOLIZUMAB | 1 | Intravenous (not otherwise specified) | 300 MG, UNK | 340236 | 0 | 300 | MG | POWDER FOR SOLUTION FOR INFUSION | ||||||
124069387 | 12406938 | 4 | C | TRAZODONE /00447702/ | TRAZODONE HYDROCHLORIDE | 1 | Oral | 100 MG, QD | 0 | 100 | MG | QD | |||||||
124069387 | 12406938 | 5 | C | CLONAZEPAM. | CLONAZEPAM | 1 | Oral | 0.5 MG, BID | 0 | .5 | MG | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124069387 | 12406938 | 1 | Dyspepsia |
124069387 | 12406938 | 2 | Colitis ulcerative |
124069387 | 12406938 | 3 | Colitis ulcerative |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124069387 | 12406938 | OT |
124069387 | 12406938 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124069387 | 12406938 | Anaemia | |
124069387 | 12406938 | Arthralgia | |
124069387 | 12406938 | Back pain | |
124069387 | 12406938 | Colitis ulcerative | |
124069387 | 12406938 | Dry eye | |
124069387 | 12406938 | Dyspepsia | |
124069387 | 12406938 | Eye swelling | |
124069387 | 12406938 | Feeling abnormal | |
124069387 | 12406938 | Frequent bowel movements | |
124069387 | 12406938 | Glossitis | |
124069387 | 12406938 | Hypoaesthesia oral | |
124069387 | 12406938 | Muscular weakness | |
124069387 | 12406938 | Myalgia | |
124069387 | 12406938 | Pulmonary mass | |
124069387 | 12406938 | Throat irritation | |
124069387 | 12406938 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124069387 | 12406938 | 1 | 201501 | 20160607 | 0 | |
124069387 | 12406938 | 3 | 20160525 | 0 |